KS1/4-DAVLB, a monoclonal antibody-vinca alkaloid conjugate for site-directed therapy of epithelial malignancies

Targeted Diagn Ther. 1988:1:55-79.

Authors

T F Bumol¹, A L Baker, E L Andrews, S V DeHerdt, S L Briggs, M E Spearman, L D Apelgren

Affiliation

¹ Lilly Research Laboratories, Indianapolis, Indiana.

PMID: 2979063

No abstract available

Publication types

Review

MeSH terms

Animals
Antibodies, Monoclonal / administration & dosage
Antibodies, Monoclonal / isolation & purification
Antibodies, Monoclonal / therapeutic use
Cell Line
Cell Survival / drug effects
Humans
Immunotoxins / therapeutic use*
Mice
Mice, Nude
Neoplasms / drug therapy*
Neoplasms, Experimental / drug therapy*
Transplantation, Heterologous
Vinca Alkaloids / administration & dosage
Vinca Alkaloids / pharmacology
Vinca Alkaloids / therapeutic use*

Substances

Antibodies, Monoclonal
Immunotoxins
Vinca Alkaloids